The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells

SF Landrette, D Madera, F He, LH Castilla - Leukemia, 2011 - nature.com
SF Landrette, D Madera, F He, LH Castilla
Leukemia, 2011nature.com
Cytokine signaling pathways are frequent targets of oncogenic mutations in acute myeloid
leukemia (AML), promoting proliferation and survival. We have previously shown that the
transcription factor PLAGL2 promotes proliferation and cooperates with the leukemia fusion
protein Cbfβ-SMMHC in AML development. Here, we show that PLAGL2 upregulates
expression of the thrombopoietin receptor Mpl, using two consensus sites in its proximal
promoter. We also show that Mpl overexpression efficiently cooperates with Cbfβ-SMMHC in …
Abstract
Cytokine signaling pathways are frequent targets of oncogenic mutations in acute myeloid leukemia (AML), promoting proliferation and survival. We have previously shown that the transcription factor PLAGL2 promotes proliferation and cooperates with the leukemia fusion protein Cbfβ-SMMHC in AML development. Here, we show that PLAGL2 upregulates expression of the thrombopoietin receptor Mpl, using two consensus sites in its proximal promoter. We also show that Mpl overexpression efficiently cooperates with Cbfβ-SMMHC in development of leukemia in mice. Finally, we demonstrate that PlagL2-expressing leukemic cells show hyper-activation of Jak2 and downstream STAT5, Akt and Erk1/2 pathways in response to Thpo ligand. These results show that PlagL2 expression activates expression of Mpl in hematopoietic progenitors, and that upregulation of wild-type Mpl provides an oncogenic signal in cooperation with CBFβ-SMMHC in mice.
nature.com